Serbian tennis star Novak Djokovic and his spouse have an 80% stake in Danish biotech firm QuantBioRes, its chief government says
Novak Djokovic and his spouse maintain a majority stake in a Danish biotech firm which is aiming to develop a medical remedy to fight coronavirus, the agency’s chief government has stated.
QuantBioRes CEO Ivan Loncarevic revealed the information to Reuters on Wednesday. The Serbian star and his spouse, Jelena, have a mixed 80% share, with 40.8% owned by the tennis ace and 39.2% held by his partner.
Loncarevic stated the tennis world primary – who has amassed over $150 million in profession prize cash – made the funding in June 2020, however didn’t disclose the quantity.
Copenhagen-based QuantBioRes is aiming to develop a ‘peptide’ remedy in opposition to Covid-19 which might inhibit the virus from infecting human cells.
It expects to launch scientific trials within the UK later this 12 months, and has round a dozen researchers working in Denmark, Australia, and Slovenia, Loncarevic defined.
The CEO careworn that it was a remedy in opposition to the sickness, relatively than a vaccine.
The information comes after Djokovic was deported from Australia in a row centered on his Covid vaccine standing.
The 34-year-old star shouldn’t be vaccinated in opposition to the sickness however arrived in Australia with a medical exemption based mostly on restoration from a previous an infection in December.
Nevertheless, that was deemed inadequate by the federal authorities.
After an ordeal lasting nearly two weeks, Djokovic was ultimately deported following the intervention of Australian Immigration Minister Alex Hawke, who argued that the Serb’s continued presence within the nation would incite anti-vaccine sentiments among the many native inhabitants.
Will Novak Djokovic be barred from different Grand Slams?
You’ll be able to share this story on social media:
Leave a Reply